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Mechanisms of glomerular macrophage infiltration in lipid- Hyperlipidemia has been shown to accelerate the in-
induced renal injury. duction and progression of renal injury leading to glo-
Background. A number of studies have demonstrated an merular sclerosis. Lipid-induced glomerular injury isimportant role for macrophages (Mφ) in lipid-induced glomeru-
thought to be mediated in part by macrophages (Mφ),lar injury; however, little is known of the mechanisms that
on the basis that glomerular Mφ accumulation is a featurefacilitate Mφ infiltration in this disease. This study examined
the expression of Mφ chemotactic molecules Mφ colony-stimu- of animal models of endogenous and diet-induced hyper-
lating factor (M-CSF) and Mφ migration inhibitory factor lipidemia, and Mφ depletion inhibits lipid-induced renal
(MIF) and leukocyte adhesion molecules intercellular adhesion
injury [1]. However, the mechanisms by which Mφ accu-molecule-1 (ICAM-1) and vascular cell adhesion molecule-1
mulate in the glomerulus during the hyperlipidemic state(VCAM-1) during the induction of glomerular Mφ infiltration
in ExHC rats, a strain that is susceptible to lipid-induced glo- are poorly understood.
merular injury. Given the similarities between the development of
Methods. Groups of five ExHC rats were fed a high-choles- atherosclerotic lesions and cellular immune responsesterol diet (HCD) containing 3% cholesterol, 0.6% sodium cho-
[2], we examined the expression of Mφ chemotactic mole-late, and 15% olive oil and were killed after three days or one,
cules Mφ colony-stimulating factor (M-CSF) and Mφ mi-two, or six weeks. Control animals were killed on day 0 or
after six weeks on a normal diet. gration inhibitory factor (MIF) and leukocyte adhesion
Results. ExHC rats fed an HCD showed marked hypercho- molecules intercellular adhesion molecule-1 (ICAM-1)
lesterolemia in the absence of any increase in plasma triglycer-
and vascular cell adhesion molecule-1 (VCAM-1) duringide levels from day 3 and developed mild proteinuria and
the induction of glomerular Mφ infiltration in exogenoussegmental glomerular lesions at week 6. Immunoperoxidase
staining identified a significant increase in glomerular ED11 hypercholesterolemic (ExHC) rats, a strain that is sus-
Mφ at week 1, which was further increased at week 6, when ceptible to lipid-induced glomerular injury [3, 4].
Mφ-derived foam cells were seen in almost all glomeruli. Many
of the infiltrating glomerular Mφ expressed lymphocyte func-
tion-associated antigen-1 (LFA-1) and very late antigen-4 METHODS
(VLA-4), which are ligands for ICAM-1 and VCAM-1, respec-
ExHC rats are derived from the Sprague-Dawleytively. Coincident with the induction of hypercholesterolemia
on day 3 and prior to significant Mφ infiltration, combined in strain and are highly susceptible to dietary hypercholes-
situ hybridization and immunohistochemistry staining demon- terolemic stimuli. Groups of five ExHC rats were fed a
strated a marked up-regulation of M-CSF and MIF mRNA
high-cholesterol diet (HCD) containing 3% cholesterol,expression by glomerular mesangial cells and podocytes. There
0.6% sodium cholate, and 15% olive oil and were killedwas also a significant increase in ICAM-1 and VCAM-1 mRNA
expression by intrinsic glomerular cells, including endothelial on day 3 or weeks 1, 2, and 6 after the start of the HCD.
cells, on day 3 of the HCD. Control animals were killed on day 0 or after six weeks
Conclusion. These results suggest that hypercholesterolemia on a normal diet.can induce a classic proinflammatory response within the kid-
ney glomerulus, involving production of well-described Mφ
chemotactic and adhesion molecules, which results in Mφ re-
RESULTS AND DISCUSSIONcruitment and the development of glomerular injury.
Clinicopathological features of ExHC rats
ExHC rats fed an HCD rapidly developed significantKey words: lipids, hypercholesterolemia, leukocyte adhesion molecule,
MIF, M-CSF. hypercholesterolemia (41 6 3, 190 6 14, 226 6 25, 423 6
36, and 362 6 27 mg/dl on days 0 and 3 and weeks 1, 2, 1999 by the International Society of Nephrology
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Fig. 1. Representative glomeruli from ExHC rats fed a cholesterol-
supplemented diet for two (a) and six weeks (b, c). (a) Some foam cells
are indicated by arrows (PAS 3200). (b) The marked accumulation of
numerous lipid-filled foam cells is visible within a glomerulus. In addi-
tion, a segmental cluster of foam cells associated with a capsular ad-
hesion and destruction of glomerular tufts can be seen (PAM 3200).
(c) ED1-positive cells correspond to foam cells within the glomerulus.
and 6, respectively; all P , 0.01 vs. day 0) and mild was further increased at week 6 (6.9 6 0.4 ED11 Mφ
per glomerular cross section; Fig. 2A).proteinuria at week 6 (21.9 6 2.7 vs. 4.3 6 0.4 mg/24 hr
on day 0, P , 0.01) but maintained normal levels of Thus, ExHC rats may be well suited for use in investi-
gations of the mechanisms that facilitate Mφ infiltrationplasma triglycerides. ExHC rats that were fed a normal
diet showed no changes in plasma lipid levels or urinary and accumulation during the development of lipid-
induced glomerular injury.protein excretion.
ExHC rats that were fed a normal diet for six weeks
Intercellular adhesion molecule-1 and vascular cellhad a normal kidney histology. In contrast, ExHC rats
adhesion molecule-1fed an HCD developed characteristic glomerular lesions,
as illustrated in Figure 1 and as described in detail pre- In situ hybridization demonstrated a significant increase
viously [3–5]. Briefly, foam cells and/or mesangial cells in glomerular ICAM-1 and VCAM-1 mRNA expression
containing lipid vacuoles were seen in 4.6 6 1.8% of after just three days on the HCD (Fig. 2B) [5]. This pre-
glomeruli on day 3. There was a progressive increase in ceded the initiation of glomerular Mφ infiltration at week 1.
The expression of Mφ ligands for ICAM-1 and VCAM-1the number and size of foam cells, and by week 6, virtu-
ally all glomeruli (97.6 6 1.6%) contained foam cells, and was examined by immunoperoxidase staining. The infil-
trating Mφ expressed lymphocyte function-associatedsegmental clusters of foam cells associated with capsular
adhesions and destruction of the glomerular tuft were antigen-1 (LFA-1) and very late antigen-4 (VLA-4), which
are ligands for ICAM-1 and VCAM-1, respectively; how-seen in 5.1 6 1.0% of glomeruli (Fig. 1 a, b). Most foam
cells within the glomeruli were identified as Mφ by the ever, there was no change in Mac-1 expression, which is
another ligand for ICAM-1. This is consistent with stud-use of a monoclonal antibody specific for rat Mφ (ED1;
Fig. 1c). There was a significant increase in glomerular ies in rat anti-glomerular basement membrane nephritis
in which glomerular polymorphonuclear leukocyte accu-ED11 Mφ at week 1 (2.0 6 0.2 vs. 1.0 6 0.1 ED11 Mφ
per glomerular cross section in day 0, P , 0.01), which mulation is mediated through the ICAM-1/Mac-1 inter-
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action, whereas an influx of mononuclear leukocytes is
mediated through the ICAM-1/LFA-1 interaction. The
potential role for the ICAM-1/LFA-1 and VCAM-1/
VLA-4 interactions in Mφ infiltration in lipid-induced
lesions is consistent with studies of atherosclerotic le-
sions in human and rabbits [6]. Moreover, in vitro study
has demonstrated that lysophospatidylcholine (Lyso-
PC) selectively increases cell surface expression of
ICAM-1 and VCAM-1 in cultured rabbit and human
arterial endothelial cells [7]. Because Lyso-PC is a com-
ponent of oxidized low-density lipoprotein (LDL) and
b-very low-density lipoprotein (VLDL), and there is a
progressive accumulation of b-VLDL in the plasma of
ExHC rats fed an HCD [4], components of lipoproteins
such as Lyso-PC may directly trigger endothelial cell
adhesion molecule expression and thereby initiate mono-
cyte recruitment in this model.
Macrophage colony-stimulating factor
Macrophage colony-stimulating factor is the main
growth factor for monocyte production in bone marrow,
is a potent chemotactic molecule for monocytes, and
can prime or directly stimulate a range of monocyte/Mφ
functions. Local production of M-CSF has been de-
scribed in vascular atherosclerotic lesions, and M-CSF
may contribute to foam cell formation by up-regulating
monocyte expression of the LDL receptor and lipid me-
tabolism. In addition, LDL has been shown to induce
M-CSF synthesis and secretion by cultured mesangial
cells [8].
Combined in situ hybridization and immunohisto-
chemistry staining showed a significant increase in the
number of glomerular M-CSF1 cells coincident with the
onset of hypercholesterolemia on day 3, which further
increased with time (Fig. 2C) [9]. Up-regulation of glo-
merular M-CSF expression preceded glomerular Mφ ac-
cumulation. Although some ED11 Mφ-derived foam
cells showed M-CSF mRNA expression, most M-CSF1
cells were intrinsic glomerular cells (mesangial cells and
podocytes).
Macrophage migration inhibitory factor
Macrophage migration inhibitory factor is a potent
proinflammatory mediator that is produced by many cell
types, including Mφ and resident kidney cells. It is re-
quired for Mφ accumulation in the skin delayed-type
hypersensitivity response and is a counter-regulator of
glucocorticoid action. We have recently shown a dra-
matic up-regulation of renal MIF expression, which me-
Fig. 2. A temporal association between glomerular macrophage infil-
diates Mφ infiltration and the development of glomerulartration (A) and glomerular ICAM-1 (B, d), VCAM-1 (B, j), M-CSF
(C, d), and MIF (C, j) expression following the induction of a high lesions in a rat model of crescentic glomerulonephritis
cholesterol diet (HCD) in ExHC rats. Glomerular ICAM-1, VCAM-1, [10]. However, the potential role for MIF to contribute
M-CSF, and MIF mRNA expression was detected by in situ hybridiza-
to Mφ recruitment in the development of lipid-inducedtion. *P , 0.05; **P , 0.01 vs. day 0 by analysis of variance or Mann–
Whitney U-test. This figure is derived from data published in Hattori renal injury is unknown.
et al and Miyazaki et al [5, 9]. We found a dramatic increase in glomerular MIF
Hattori et al: Macrophages in lipid-induced glomerular injuryS-50
Reprint requests to Motoshi Hattori, M.D., Department of PediatricmRNA expression on day 3 after the start of the HCD,
Nephrology, Kidney Center, Tokyo Women’s Medical University, School
which further increased over the six-week period (Fig. of Medicine, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan.
2C) [9]. The up-regulation of glomerular MIF expression E-mail: jq6m-httr@asahi-net.or.jp
preceded Mφ infiltration. Although double staining iden-
tified MIF expression by 32% of ED11 Mφ, the main REFERENCES
source of the increased glomerular MIF production was 1. Keane WF: Lipids and the kidney. Kidney Int 46:910–920, 1994
intrinsic glomerular cells, particularly podocytes. 2. Ross R: The pathogenesis of atherosclerosis: A perspective for
the 1990s. Nature 362:801–809, 1993Currently, we do not know whether the up-regulation
3. Hattori M, Yamaguchi Y, Kawaguchi H, Ito K: Characteristicof glomerular MIF expression is a direct or indirect effect glomerular lesions in the ExHC rat: A unique model for lipid-
of hypercholesterolemia. Given the ability of MIF to acti- induced glomerular injury. Nephron 63:314–322, 1993
4. Hattori M, Ito K, Kawaguchi H, Yamaguchi Y: Probucol reducevate Mφ and inhibit migration of Mφ [10], this cytokine
renal injury in the ExHC rat. Nephron 67:459–468, 1994may play a similar key role in promoting Mφ accumula-
5. Hattori M, Nikolic-Paterson DJ, Lan HY, Kawaguchi H, Ito
tion and the subsequent development of lipid-induced K, Atkins RC: Up-regulation of ICAM-1 and VCAM-1 expression
during macrophage recruitment in lipid induced glomerular injuryglomerular injury.
in ExHC rats. Nephrology 1:221–232, 1995
6. Faruqi RM, DiCorleto PE: Mechanisms of monocyte recruitment
and accumulation. Br Heart J 69(Suppl):S19–S29, 1993SUMMARY 7. Kume N, Cybulsky MI, Gimbrone MA Jr: Lysophosphatidylcho-
line, a component of atherogenic lipoproteins, induces mononu-These results suggest that hypercholesterolemia can
clear leukocyte adhesion molecules in cultured human and rabbitinduce a classic proinflammatory response within the kid-
arterial endothelial cells. J Clin Invest 90:138–144, 1992
ney glomerulus, involving production of well-described 8. Fixe P, Praloran V: Macrophage colony-stimulating-factor (M-
CSF or CSF-1) and its receptor: Structure-function relationships.Mφ chemotactic and adhesion molecules, which results
Eur Cytokine Netw 8:125–136, 1997in Mφ recruitment and the development of glomerular
9. Miyazaki K, Isbel NM, Lan HY, Hattori M, Ito K, Bacher M,
injury. Bucala R, Atkins RC, Nikolic-Paterson DJ: Up-regulation of
macrophage colony-stimulating factor (M-CSF) and migration in-
hibitory factor (MIF) expression and monocyte recruitment duringACKNOWLEDGMENTS
lipid-induced glomerular injury in the exogenous hypercholestero-
laemic (ExHC) rat. Clin Exp Immunol 108:318–323, 1997A portion of this work was supported by a Grant-in-Aid for General
10. Lan HY, Bacher M, Yang N, Mu W, Nikolic-Paterson DJ, MetzScientific Research (C) (08671306 and 08671307) from the Japanese
C, Meinhardt A, Bucala R, Atkins RC: The pathogenic role ofMinistry of Education, Science and Culture, and by Dr. Itoe Okamoto
macrophage migration inhibitory factor in immunologically in-International Exchange Fund (Tokyo Women’s Medical University,
duced kidney disease in the rat. J Exp Med 185:1455–1465, 1997School of Medicine, Tokyo, Japan).
